Sundar.M
☆    

India,
2019-02-15 14:37
(1893 d 13:39 ago)

Posting: # 19925
Views: 1,802
 

 Dose curve [PK / PD]

Post reply
Dear all,

How to choose dose for any PK/PD study (without non-clinical data) in healthy volunteer for Phase-1 trials for already marketed product? Other words, how to choose the proposed dose to detect clinically meaningful differences in PK/PD responses?

Thanks for your help.

Thanks
MSMN
 
UA Flag
Activity
 Admin contact
22,990 posts in 4,826 threads, 1,664 registered users;
35 visitors (0 registered, 35 guests [including 7 identified bots]).
Forum time: 05:17 CEST (Europe/Vienna)

If you don’t like something change it;
if you can’t change it, change the way you think about it.    Mary Engelbreit

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5